Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID 19 outpatients meta-analysis

CoV-Early (Gharbharan)
 
NCT04589949
RCTconvalescent plasma treatmentplaceboCOVID 19 outpatientslow
207/209 inconclusive
    CoV-Early (Gharbharan)
     
    NCT04589949
    RCTEarly convalescent plasma.placeboCOVID 19 outpatientslow
    207/209 inconclusive
      CONV-ERT
       
      NCT04621123
      RCTconvalescent plasma treatmentplaceboCOVID 19 outpatientslow
      188/160 inconclusive
        C3PO
         
        NCT04355767
        RCTconvalescent plasma treatmentplaceboCOVID 19 outpatientssome concern
        257/254 inconclusive
        • inconclusive 9 % decrease in hospitalization or death (PE) with a moderate degree of certainty due to some concern in risk of bias

        PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
        Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).